Form 8-K for PEAK PHARMACEUTICALS, INC.
Entry into a Material Definitive Agreement, Financial Statements and E
As permitted by Chapter 92A.180 of Nevada Revised Statutes, the sole purpose of the Merger was to effect a change of the Company’s name from Cannabis Therapy Corp., to Peak Pharmaceuticals, Inc. Upon the filing of Articles of Merger (the “Articles of Merger”) with the Secretary of State of Nevada on December 24, 2014 to effect the Merger, the Company’s Articles of Incorporation were deemed amended to reflect the change in the Company’s corporate name.
A copy of the Articles of Merger as filed with the Secretary of State of Nevada on December 24, 2014, is attached as Exhibit 2.1. A copy of the Merger Agreement dated December 23, 2014, is attached as Exhibit 2.2.
The Company’s common stock will temporarily remain listed for quotation on OTC Markets under the current symbol “CTCO” until a new symbol is assigned by Financial Industry Regulatory Authority, Inc. (FINRA). The Company will publicly announce the new trading symbol when assigned by FINRA and the effective date of the symbol change.
The name change was made to make our name more consistent with our business operations and plans relating to development, manufacturing and marketing of hemp-based nutraceutical and supplement products for the human and animal health markets.
Exhibits filed as part of this Current Report are as follows:
Exhibit Number Description 2.1 Articles of Merger as filed with the Nevada Secretary of State on December 24, 2014 2.2 Agreement and Plan of Merger, dated December 23, 2014, by and between Cannabis Therapy Corp and Peak Pharmaceuticals, Inc.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org